ALTS Quote, Financials, Valuation and Earnings

Aurora Innovation has a net margin of -16.64% compared to ALT5 Sigma's net margin of --. ALT5 Sigma's return on equity of -173.63% beat Aurora Innovation's return on equity of --.

ALT5 Sigma has a consensus price target of --, signalling downside risk potential of --. On the other hand Aurora Innovation has an analysts' consensus of -- which suggests that it could fall by -24.57%. Given that Aurora Innovation has higher upside potential than ALT5 Sigma, analysts believe Aurora Innovation is more attractive than ALT5 Sigma.

ALT5 Sigma has a beta of 2.080, which suggesting that the stock is 107.999% more volatile than S&P 500. In comparison Aurora Innovation has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

ALT5 Sigma has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Aurora Innovation offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. ALT5 Sigma pays -- of its earnings as a dividend. Aurora Innovation pays out -- of its earnings as a dividend.

ALT5 Sigma quarterly revenues are $4.9M, which are larger than Aurora Innovation quarterly revenues of --. ALT5 Sigma's net income of -$822K is higher than Aurora Innovation's net income of -$208M. Notably, ALT5 Sigma's price-to-earnings ratio is -- while Aurora Innovation's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for ALT5 Sigma is -- versus 163.51x for Aurora Innovation. Usually stocks with elevated PS ratios are considered overvalued.

Cantaloupe has a net margin of -16.64% compared to ALT5 Sigma's net margin of 5.04%. ALT5 Sigma's return on equity of -173.63% beat Cantaloupe's return on equity of 7.51%.

ALT5 Sigma has a consensus price target of --, signalling downside risk potential of --. On the other hand Cantaloupe has an analysts' consensus of $11.50 which suggests that it could grow by 18.19%. Given that Cantaloupe has higher upside potential than ALT5 Sigma, analysts believe Cantaloupe is more attractive than ALT5 Sigma.

ALT5 Sigma has a beta of 2.080, which suggesting that the stock is 107.999% more volatile than S&P 500. In comparison Cantaloupe has a beta of 1.659, suggesting its more volatile than the S&P 500 by 65.884%.

ALT5 Sigma has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Cantaloupe offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. ALT5 Sigma pays -- of its earnings as a dividend. Cantaloupe pays out -- of its earnings as a dividend.

ALT5 Sigma quarterly revenues are $4.9M, which are smaller than Cantaloupe quarterly revenues of $70.8M. ALT5 Sigma's net income of -$822K is lower than Cantaloupe's net income of $3.6M. Notably, ALT5 Sigma's price-to-earnings ratio is -- while Cantaloupe's PE ratio is 57.24x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for ALT5 Sigma is -- versus 2.61x for Cantaloupe. Usually stocks with elevated PS ratios are considered overvalued.

Paycor HCM has a net margin of -16.64% compared to ALT5 Sigma's net margin of -4.35%. ALT5 Sigma's return on equity of -173.63% beat Paycor HCM's return on equity of -3.56%.

ALT5 Sigma has a consensus price target of --, signalling downside risk potential of --. On the other hand Paycor HCM has an analysts' consensus of $21.50 which suggests that it could grow by 12.1%. Given that Paycor HCM has higher upside potential than ALT5 Sigma, analysts believe Paycor HCM is more attractive than ALT5 Sigma.

ALT5 Sigma has a beta of 2.080, which suggesting that the stock is 107.999% more volatile than S&P 500. In comparison Paycor HCM has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

ALT5 Sigma has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Paycor HCM offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. ALT5 Sigma pays -- of its earnings as a dividend. Paycor HCM pays out -- of its earnings as a dividend.

ALT5 Sigma quarterly revenues are $4.9M, which are smaller than Paycor HCM quarterly revenues of $167.5M. ALT5 Sigma's net income of -$822K is higher than Paycor HCM's net income of -$7.3M. Notably, ALT5 Sigma's price-to-earnings ratio is -- while Paycor HCM's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for ALT5 Sigma is -- versus 5.03x for Paycor HCM. Usually stocks with elevated PS ratios are considered overvalued.

Veea has a net margin of -16.64% compared to ALT5 Sigma's net margin of -65748.98%. ALT5 Sigma's return on equity of -173.63% beat Veea's return on equity of --.

ALT5 Sigma has a consensus price target of --, signalling downside risk potential of --. On the other hand Veea has an analysts' consensus of -- which suggests that it could fall by --. Given that ALT5 Sigma has higher upside potential than Veea, analysts believe ALT5 Sigma is more attractive than Veea.

ALT5 Sigma has a beta of 2.080, which suggesting that the stock is 107.999% more volatile than S&P 500. In comparison Veea has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

ALT5 Sigma has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Veea offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. ALT5 Sigma pays -- of its earnings as a dividend. Veea pays out -- of its earnings as a dividend.

ALT5 Sigma quarterly revenues are $4.9M, which are larger than Veea quarterly revenues of $50.7K. ALT5 Sigma's net income of -$822K is higher than Veea's net income of -$33.3M. Notably, ALT5 Sigma's price-to-earnings ratio is -- while Veea's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for ALT5 Sigma is -- versus -- for Veea. Usually stocks with elevated PS ratios are considered overvalued.